EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer

Shiori Fujisawa, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, Ai Sato, Yasuhiro Miki, Minoru Miyashita, Hiroshi Tada, Takanori Ishida, Takashi Suzuki

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Shiori Fujisawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan; Department of Pa…. Hauptthemen laut MEDLINE: Hyaluronoglucosaminidase, Breast Neoplasms, Hyaluronic Acid, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyaluronan (HA), as a component of extracellular matrix, has pivotal roles in both physiological and pathological condition. In breast cancer, while high molecular weight HA is produced by hyaluronan synthase, it is degraded by hyaluronidases (hyaluronidase-1 (HYAL1) and hyaluronidase-2 (HYAL2)) into low molecular weight HA (LMW HA), which is considered to have pro-tumorigenic effects in human malignancies. However, HA and HYAL2, the rate-limiting enzyme of HA degradation, have not been comprehensively examined in breast cancer and clinicopathological significance of LMW HA remains to be elucidated in breast cancer. We therefore histochemically localized HA as well as HYAL2 in 116 breast cancer tissues. In addition, we examined size-dependent function of HA on breast cancer cell proliferation and migration using MCF-7 and MDA-MB-231 breast cancer cell lines. HA was localized in both the stroma and breast carcinoma cells, while HYAL2 was predominantly localized in breast carcinoma cells. HA was significantly correlated with cell proliferation and invasion ability as well as increased risk of recurrence especially in HYAL2 positive group. On the other hand, HYAL2 was correlated with breast cancer cell proliferation and increased risk of recurrence. In addition, in vitro analyses revealed that lower molecular weight HA increased sphere forming ability and migration in MCF-7 and MDA-MB-231, whereas higher molecular weight HA inhibited them. It was concluded that HA needs to be degraded by HYAL2 to exert pro-tumorigenic effects and comprehensive HA/HYAL2 status serves as a potent prognostic factor in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyaluronoglucosaminidaseBreast NeoplasmsHyaluronic AcidCell ProliferationCell MovementHumansFemaleMiddle AgedAdultAgedGPI-Linked ProteinsCell Line, TumorCell Adhesion MoleculesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Breast cancerHyaluronanHyaluronidase (HYAL2)Prognosis

Substanzen

HyaluronoglucosaminidaseHyaluronic AcidHyal2 protein, humanGPI-Linked ProteinsCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan; Department of Pathology and Histotechnology, Tohoku University Graduate School of Medi…
  • Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan. Electronic address: kiyoshi.takagi.b7@tohoku.ac.jp.
  • Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan; Department of Personalized Medicine Center and Tohoku University Hospital, Sendai, Miyagi 980-8…
  • Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Fujisawa, S., Takagi, K., Yamaguchi-Tanaka, M., Sato, A., Miki, Y., Miyashita, M., Tada, H., Ishida, T., & Suzuki, T. (2024). Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155434

Vancouver

Fujisawa S, Takagi K, Yamaguchi-Tanaka M, Sato A, Miki Y, Miyashita M, et al. Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155434

BibTeX
@article{Fujisawa2024,
  author = {Fujisawa, Shiori and Takagi, Kiyoshi and Yamaguchi-Tanaka, Mio and Sato, Ai and Miki, Yasuhiro and Miyashita, Minoru and Tada, Hiroshi and Ishida, Takanori and Suzuki, Takashi},
  title = {Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155434}
}
Kostenlos starten →